# Children with autism spectrum disorder and attention deficit hyperactivity disorder have evidence of sensory nerve degeneration

**Authors:** Hoda Gad, Abdulla AlObaidi, Madeeha Kamal, Saba F. Elhag, Marian Aden, Adnan Khan, Areej Baraka, Srividya Bennabhaktula, Sara Joseph, Aisha Yaseen Alhamadi, Mohammed A. Tolefat, Abdulla A. Alhothi, Rayaz A. Malik, Shivanand Kattimani, Shivanand Kattimani, Shivanand Kattimani, Shivanand Kattimani, Shivanand Kattimani, Shivanand Kattimani

PMC · DOI: 10.1371/journal.pone.0342439 · PLOS One · 2026-02-23

## TL;DR

This study found signs of sensory nerve degeneration in children with autism and ADHD using a non-invasive eye imaging technique.

## Contribution

The study is the first to use corneal confocal microscopy to detect sensory nerve changes in children with ASD and ADHD.

## Key findings

- Children with ASD+ADHD and ASD had significantly lower corneal nerve branch density compared to healthy controls.
- Corneal nerve fiber length was reduced in children with ASD but not in those with ASD+ADHD.
- No correlation was found between corneal nerve parameters and ASD severity.

## Abstract

An increasing body of evidence supports the role of altered sensory processing in autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). This exploratory study undertook corneal confocal microscopy (CCM) to assess for differences in corneal nerve fiber density (CNFD), branch density (CNBD) and fiber length (CNFL) in relation to ASD severity in children with ASD+ADHD (n = 21), ASD (n = 6) and healthy controls (HC) (n = 15). CNBD was significantly lower in children with ASD+ADHD (P = 0.002) and ASD (P < 0.001) and CNFL was significantly lower in children with ASD (P = 0.02) compared to HC. However, CNFD (mean difference = 2.28, 95% CI [−5.84, 10.40], P > 0.99) CNBD (mean difference = 14.1, 95% CI [−8.22, 36.4], p = 0.37) and CNFL (mean difference = 2.46, 95% CI [−2.28, 7.20], p = 0.61) did not differ between ASD+ADHD and ASD. CNFD (P = 0.876), CNBD (P = 0.405) and CNFL (P = 0.606) did not correlate with the severity of ASD. Corneal confocal microscopy reveals sensory nerve degeneration in children with ASD+ADHD and ASD alone compared to controls. Larger studies integrating CCM with sensory and cognitive assessment are required to determine the utility of CCM as a clinical screening strategy for neurodegneration in ASD, ADHD and ASD-ADHD combined.

## Linked entities

- **Diseases:** autism spectrum disorder (MONDO:0005258), attention-deficit/hyperactivity disorder (MONDO:0007743)

## Full-text entities

- **Genes:** NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}
- **Diseases:** chronic renal failure (MESH:D007676), ADHD (MESH:D001289), agitation (MESH:D011595), diabetic neuropathy (MESH:D003929), rheumatoid arthritis (MESH:D001172), allodynia (MESH:D006930), corneal alterations (MESH:D065306), neurodevelopmental disorder (MESH:D002658), HIV-neuropathy (MESH:D015658), multiple sclerosis (MESH:D009103), neuropathy (MESH:D009422), cognitive impairment (MESH:D003072), Disabilities (MESH:D009069), deficits in social communication and interaction (MESH:D003147), impulsivity (MESH:D007174), astigmatism (MESH:D001251), depression (MESH:D003866), Sensory Nerve Degeneration (MESH:D009410), dementia (MESH:D003704), Raynaud phenomenon (MESH:D011928), liver failure (MESH:D017093), diabetic and other peripheral neuropathies (MESH:D010523), Ophthalmologic abnormalities (MESH:C536647), COMMA MISSING (MESH:D000030), sensory abnormalities (MESH:D012678), malignancy (MESH:D009369), Mental Disorders (MESH:D001523), anxiety (MESH:D001007), myopia (MESH:D009216), Autism (MESH:D001321), loss of (MESH:D016388), inattention (MESH:D001308), hypermetropia (MESH:D006956), CNFD (MESH:D000071075), chronic inflammatory demyelinating neuropathy (MESH:D020277), neurodegeneration (MESH:D019636), , repetitive behaviour (MESH:D012090), neurodevelopmental condition (MESH:D020763), Parkinson disease (MESH:D010300), ID (MESH:C537985), pain (MESH:D010146), ASD (MESH:D000067877), sleep disorders (MESH:D012893), CCM (MESH:D003316), amblyopia (MESH:D000550), HC (MESH:D000067329), hyperactivity (MESH:D006948), difficulties (MESH:D051346), systemic scleroderma (MESH:D012595), systemic disease (MESH:D034721), dermatomyositis (MESH:D003882), systemic lupus erythematosus (MESH:D008180), strabismus (MESH:D013285), deficiency of B12 or folate (MESH:D014806), anisometropia (MESH:D015858)
- **Chemicals:** methylphenidate (MESH:D008774), Oxybuprocaine hydrochloride (MESH:C005298), Bausch (-), Carbomer (MESH:C479038)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928439/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12928439/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928439/full.md

---
Source: https://tomesphere.com/paper/PMC12928439